| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.23 | 0.1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |